Inlay

In @jama.com, we identify a blind spot for FDA-listed AI/ML devices 🤖🔍 Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database) As AI enters care, transparency can’t lag jamanetwork.com/journals/jam...

8mo

This study examines the extent and nature of payments made to health care professionals and teaching hospitals by manufacturers of FDA-authorized AI- and machine learning–enabled devices.

jamanetwork.com

Payments by AI- and Machine Learning–Enabled Medical Device Manufacturers

9mo

Manufacturers of >90% of FDA-listed #AI- and machine learning–enabled devices publicly disclosed no payments to clinicians or teaching hospitals from 2017-2023, but the $ amount of general payments doubled in that time frame. ja.ma/3VVS9WB

David-Dan Nguyen

JAMA